F&S SUMMIT

After entering China for 27 years, how do global consulting giants view the future of the Chinese market?

2025 Annual Highlights - 19th Annual Frost & Sullivan Summit

NIE 2025 | Wang Li, Chief Physician at iHeartCare: Development Trends of the New Generation of Cardiovascular Diagnostic and Therapeutic Devices

NIE 2025 | Cao Le, Director of Strategic Investment at iHealthTech Asia-Pacific: Analysis of New Trends in the Consumer Healthcare Ecosystem

NIE 2025 | Hongyuan Bio Zhang Jiangli: Challenges and Opportunities for Early Cancer Screening Technology

NIE 2025 | Tongrui Biopharmaceutical (Shanghai) Co., Ltd. Jing Lan: RDC Industry Development and Opportunities: Current Status of Cu-64-labeled Radiopharmaceutical Development

NIE 2025 | Cai Jiangnan from Shanghai Chuangqi Health Development Research Institute: The latest policy developments in the healthcare industry

NIE 2025 | Lin Zirong from CanSino Biologics Co., Ltd.: Exploration and Practice of Mitochondrial Medicine in Longevity Medicine

NIE 2025 | Xiaozhaoxiang from Zhejiang Shimai Pharmaceutical Co., Ltd.: Prospects and Analysis of the New Generation TCE Technology

NIE 2025 | Frost & SullivanRhenu Bhuller: The Future of Healthcare: Innovation, Investment and Global Collaboration – Activating China's Potential

NIE 2025 | Ernst & Young Wu Jiaeye: Developing New-Quality Productivity and Accelerating Energy Transformation

NIE 2025 | Expert Interviews: Corporate ESG Management and the Integration of AI with ESG

NIE 2025 | Taxpayer Shares Zhou Yuan: Commercialization Exploration of Agent Products under the Artificial Intelligence Wave

NIE 2025 | Singauto Chen Jianfeng: How New Energy Commercial Vehicles Embrace the Growing Demand for Global Cold Chain Logistics

NIE 2025 | Proton Motors Li Man: Zero-Carbon Smart Transportation Practices and Explorations

NIE 2025 | Ernst & Young's Tang Zhehui: When ESG Meets New Productivity Drivers, a Beautiful Sci-Tech Odyssey Begins